UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

The New England journal of medicine, 2018-01, Vol.378 (4), p.354-369

2018

Volltextzugriff (PDF)

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.872-875

2010

Volltextzugriff (PDF)

Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients

Arthritis care & research (2010), 2010-04, Vol.62 (4), p.569-574

2010

Volltextzugriff (PDF)

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2405-2416

2011

Volltextzugriff (PDF)

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study

Journal of viral hepatitis, 2020-03, Vol.27 (3), p.281-293

2020

Volltextzugriff (PDF)

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4528-4535

2002

Volltextzugriff (PDF)

The effect of labour induction on the risk of caesarean delivery: using propensity scores to control confounding by indication

BJOG : an international journal of obstetrics and gynaecology, 2016-08, Vol.123 (9), p.1521-1529

2016

Volltextzugriff (PDF)

Comparing expectant management and spontaneous labor approaches in studying the effect of labor induction on cesarean delivery

Annals of epidemiology, 2016-06, Vol.26 (6), p.405-411.e1

2016

Volltextzugriff (PDF)

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

Journal of hepatology, 2013-03, Vol.58 (3), p.467-472

2013

Volltextzugriff (PDF)

Development and Validation of a Risk Prediction Model for Cesarean Delivery After Labor Induction

Journal of women's health (Larchmont, N.Y. 2002), 2020-05, Vol.29 (5), p.656

2020

Volltextzugriff (PDF)

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

JAMA : the journal of the American Medical Association, 2015-05, Vol.313 (17), p.1728

2015

Volltextzugriff (PDF)

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks

Nature (London), 2021-09, Vol.597 (7877), p.539-543

2021

Volltextzugriff (PDF)

Obesity alters monocyte developmental trajectories to enhance metastasis

The Journal of experimental medicine, 2023-08, Vol.220 (8)

2023

Volltextzugriff (PDF)

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2152-2160

2014

Volltextzugriff (PDF)

Histone Deacetylase Inhibition Induces Odor Preference Memory Extension and Maintains Enhanced AMPA Receptor Expression in the Rat Pup Model

Learning & memory (Cold Spring Harbor, N.Y.), 2017-10, Vol.24 (10), p.543-551

2017

Volltextzugriff (PDF)

Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1

Hepatology (Baltimore, Md.), 2011-04, Vol.53 (4), p.1109-1117

2011

Volltextzugriff (PDF)

Impact of high‐dose peginterferon alfa‐2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

Hepatology (Baltimore, Md.), 2009-10, Vol.50 (4), p.1045-1055

2009

Volltextzugriff (PDF)

A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism

The American journal of medicine, 2002-04, Vol.112 (5), p.348-354

2002

Volltextzugriff (PDF)

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC 3 Study

Journal of viral hepatitis, 2017-01, Vol.24 (1), p.43-52

2017

Volltextzugriff (PDF)

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

HIV medicine, 2003-07, Vol.4 (3), p.241-249

2003

Volltextzugriff (PDF)

The effect of hepatitis C virus infection on health-related quality of life in prisoners

Journal of urban health, 2006-03, Vol.83 (2), p.275-288

2006

Volltextzugriff (PDF)

The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia

Journal of leukocyte biology, 2007-11, Vol.82 (5), p.1340-1343

2007

Volltextzugriff (PDF)

Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema

Clinical Immunology, 2007-04, Vol.123 (1), p.14-17

2007

Volltextzugriff (PDF)

Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial

HIV medicine, 2015-04, Vol.16 (S1), p.1-9

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

The effect of labour induction on the risk of caesarean delivery: using propensity scores to control confounding by indication

Comparing expectant management and spontaneous labor approaches in studying the effect of labor induction on cesarean delivery

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

Development and Validation of a Risk Prediction Model for Cesarean Delivery After Labor Induction

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks

Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

Obesity alters monocyte developmental trajectories to enhance metastasis

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

Histone Deacetylase Inhibition Induces Odor Preference Memory Extension and Maintains Enhanced AMPA Receptor Expression in the Rat Pup Model

Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1

Impact of high‐dose peginterferon alfa‐2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC 3 Study

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

The effect of hepatitis C virus infection on health-related quality of life in prisoners

The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia

Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema

Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial

Aktive Filter

Suchergebnisse filtern